Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
21:22
Praxis Precision Medicines shares fall after hours as the US FDA extends the review period for its epilepsy drug by 3 months
Affected by this news, the company's stock price fell 5.9% after hours. The FDA has set a revised PDUFA (Prescription Drug User Fee Act) target action date for December 27, 2026, instead of the previous PDUFA date of September 27. This postponement occurred after Praxis submitted an additional sensitivity analysis regarding existing clinical data. The FDA has classified this submission as a major amendment, thereby allowing additional review time. The FDA has not requested any new clinical studies nor raised any concerns related to safety or manufacturing.
21:15
Aeon Acquisition I Corp. has announced through a filing with the U.S. Securities and Exchange Commission that its Class A common stock, warrants, and rights will begin separate trading on July 1, 2026.
This move means that these securities components, which were previously issued as unit combinations, will now be able to be bought and sold separately. Investors will have greater flexibility in configuring their portfolios and can adopt independent trading strategies for different securities components. This change is expected to provide higher liquidity to the market and may impact the valuation and trading dynamics of related securities.
21:15
The U.S. Department of Agriculture reports: Ratings for U.S. corn and soybean crops decline, while spring wheat conditions improve
Corn is rated below last year's 73% at this time (when it was rated good to excellent), but matches the rating for the same period in 2024. According to the U.S. Department of Agriculture, the growth of soybean crops is the worst in three years. Expand
News